MedPath
HSA Approval

POLI-FLUNARIN CAPSULE 5 mg

SIN09449P

POLI-FLUNARIN CAPSULE 5 mg

POLI-FLUNARIN CAPSULE 5 mg

July 23, 1997

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMD PHARMACEUTICALS PTE. LTD.
Licence HolderMD PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N07CA03

flunarizine

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

POLIPHARM CO LTD

Active Ingredients

FLUNARIZINE HCl EQV FLUNARIZINE

5 mg

Flunarizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLI-FLUNARIN CAPSULE 5 mg - HSA Approval | MedPath